AZN Astrazeneca Plc

11,626.00

26.00 (0.22%)

Last Updated: 11:56:30

Delayed by 15 minutes

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Astrazeneca Plc	LSE:AZN	London	Ordinary Share	GB0009895292	ORD SHS $0.25

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	26.00	0.22%	11,626.00	11,624.00	11,628.00	11,682.00	11,526.00	11,584.00	224,157	11:56:30

Industry Sector	Turnover	Profit	EPS - Basic	PE Ratio	Market Cap
Pharmaceutical Preparations	45.81B	5.96B	3.8406	30.29	179.86B

AstraZeneca Increases Stake in U.S. Biotech Firm Moderna Therapeutics

10/08/2016 3:55pm

Dow Jones News

Astrazeneca (LSE:AZN)
Historical Stock Chart

From Feb 2020 to Feb 2025

LONDON--AstraZeneca PLC (AZN.LN) on Wednesday said it has increased its equity interest in U.S.-based biotechnology company Moderna Therapeutics with a $140 million investment.

The U.K.-listed pharmaceutical company now owns a 9% stake in Moderna after the transaction, which was made as part of Moderna's preferred-stock financing.

AstraZeneca previously acquired an equity stake in Moderna after a collaboration agreement, announced in March 2013, to develop medicines for cardiovascular, metabolic and renal diseases, as well as oncology. The companies also entered into a further collaboration agreement in January 2016 to develop and commercialize cancer medicines.

Shares of AstraZeneca at 1352 GMT were trading 0.6% lower at 5,147 pence.

Write to Tapan Panchal at tapan.panchal@wsj.com

(END) Dow Jones Newswires

August 10, 2016 10:40 ET (14:40 GMT)